Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

24.75 +0.42 (+1.73%)
Streaming Delayed Price Updated: 12:20 PM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
 
Via Benzinga
8 Analysts Have This to Say About IDEAYA Biosciences
 
Via Benzinga
The Latest Analyst Ratings for IDEAYA Biosciences
 
Via Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
Via Benzinga
Why Ideaya Biosciences Stock Is Plummeting Today
Ideaya stock is getting hit hard following a recent press release from the company. 
Via The Motley Fool
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants. 
Via Benzinga
Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Where IDEAYA Biosciences Stands With Analysts
 
Via Benzinga
7 Analysts Have This to Say About IDEAYA Biosciences
 
Via Benzinga
Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT... 
Via Benzinga
The Latest Analyst Ratings for IDEAYA Biosciences
 
Via Benzinga
Analyst Expectations for IDEAYA Biosciences's Future
 
Via Benzinga
Ideaya Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 5/11
Via Investor Brand Network
Top 5 Health Care Stocks That May Fall Off A Cliff
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
 
Via Benzinga
Recap: IDEAYA Biosciences Q1 Earnings
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
IDEAYA Biosciences: Q1 Earnings Insights
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment. 
Via Benzinga
Nasdaq Turns Lower Ahead Of Big Week For Tech
The Nasdaq Composite Index has begun to slip deeper into the red ahead of this week's slew of Big Tech earnings. 
Via Talk Markets
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around 14,000 In US and Europe
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
 
Via Benzinga
US Stocks Edge Higher; Coca-Cola Posts Upbeat Results
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 30 points on Monday. Following the market opening Monday, the Dow traded up 0.10% to 33,843.10 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Philips, Credit Suisse And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.